Revenue Breakdown
Composition ()
No data
Revenue Streams
Merit Medical Systems Inc (MMSI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Peripheral Intervention, accounting for 37.7% of total sales, equivalent to $144.78M. Other significant revenue streams include Cardiac Intervention and Custom Procedural Solutions. Understanding this composition is critical for investors evaluating how MMSI navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Merit Medical Systems Inc maintains a gross margin of 48.52%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 11.09%, while the net margin is 7.22%. These profitability ratios, combined with a Return on Equity (ROE) of 8.30%, provide a clear picture of how effectively MMSI converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, MMSI competes directly with industry leaders such as CELC and TFX. With a market capitalization of $4.89B, it holds a significant position in the sector. When comparing efficiency, MMSI's gross margin of 48.52% stands against CELC's N/A and TFX's 49.47%. Such benchmarking helps identify whether Merit Medical Systems Inc is trading at a premium or discount relative to its financial performance.
